Akari Therapeutics (AKTX) Enterprise Value (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.80% |
| Dec 31, 2025 | -3,100.53% |
| Sep 30, 2025 | 94.00% |
| Jun 30, 2025 | -5.00% |
| Mar 31, 2025 | 0.65% |
| Dec 31, 2024 | -15.72% |
| Sep 30, 2024 | 46.23% |
| Jun 30, 2024 | -218.85% |
| Mar 31, 2024 | 65.93% |
| Jun 30, 2022 | 51.26% |
| Mar 31, 2022 | -179,345.25% |
| Dec 31, 2021 | 99.93% |
| Sep 30, 2021 | 4.73% |
| Jun 30, 2021 | -110.78% |
| Mar 31, 2021 | 99.88% |
| Dec 31, 2020 | -46,304.40% |
| Sep 30, 2020 | 3.36% |
| Jun 30, 2020 | -62.95% |
| Mar 31, 2020 | -36.85% |
| Dec 31, 2019 | 4.22% |
| Sep 30, 2019 | -116.70% |
| Jun 30, 2019 | 54.97% |
| Mar 31, 2019 | 4.97% |
| Dec 31, 2018 | 39.26% |
| Sep 30, 2018 | 32.05% |
| Jun 30, 2018 | 34.83% |
| Mar 31, 2018 | 15.31% |
| Dec 31, 2017 | -33.78% |
| Sep 30, 2017 | 38.07% |
| Jun 30, 2017 | 22.71% |
| Mar 31, 2017 | 0.04% |
| Dec 31, 2016 | 61.29% |
| Sep 30, 2016 | 0.89% |
| Jun 30, 2016 | -87.27% |
| Mar 31, 2016 | 10.87% |
| Dec 31, 2015 | -1,971.24% |
| Sep 30, 2015 | 0.00% |
| Jun 30, 2015 | -150.44% |
| Mar 31, 2015 | 60.07% |
| Dec 31, 2014 | -6,224.30% |
| Sep 30, 2014 | 99.54% |
| Jun 30, 2014 | 17.86% |
| Mar 31, 2014 | -2,397.59% |